No difference in serum levels of B-cell activating receptor and antibodies against cytolethal distending toxin B and flagellin in post-infectious irritable bowel syndrome and chronic fatigue syndrome after Giardia infection.
Kurt HanevikChristina Skår SaghaugMaren AalandKristine MorchNina LangelandPublished in: JGH open : an open access journal of gastroenterology and hepatology (2022)
BAFF, anti-CdtB, or anti-flagellin antibodies cannot be considered as universal biomarkers for IBS or CFS.